In an analysis performed in patients with stages III and IV melanoma, a high Id1 expression significantly correlated with the expression of phenotypic and immunosuppressive markers of human monocytic myeloid-derived suppressor cells, and Id1 downregulation in healthy donors led to differentiation from the monocytic lineage to a more immunogenic phenotype [42]. Here, ID1 is linked to melanoma.